Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Provencher

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Clinical & Experimental Metastasis|January 6, 2010
Protease inhibitor SERPINA1 expression in epithelial ovarian cancerKarine Normandin, Benjamin Péant, Cécile Le Page, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2004
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2AV Samouëlian, C M Maugard, M Jolicoeur, et al.
International Journal of Oncology|January 29, 2013
FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcomeMichael C J Quinn, Paulina M Wojnarowicz, Amy Pickett, et al.
British Journal of Cancer|January 20, 2006
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancerC Le Page, V Ouellet, J Madore, et al.
International Journal of Cancer|June 15, 2019
Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control studyAnne Grundy, Vikki Ho, Michal Abrahamowicz, et al.
Translational Oncology|August 7, 2010
Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro modelLiliane Meunier, Marie-Line Puiffe, Cécile Le Page, et al.
The Journal of Pathology|December 8, 2009
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinomaJason Madore, Fengge Ren, Ali Filali-Mouhim, et al.
International Journal of Cancer|March 31, 2006
Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancerVéronique Ouellet, Marie-Claude Guyot, Cécile Le Page, et al.
British Journal of Cancer|November 15, 2007
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimensC N Krasner, D S McMeekin, S Chan, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
BMC Medical Genetics|January 11, 2013
Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descentMarc Tischkowitz, Nelly Sabbaghian, Nancy Hamel, et al.
Clinical & Experimental Metastasis|January 6, 2010
Protease inhibitor SERPINA1 expression in epithelial ovarian cancerKarine Normandin, Benjamin Péant, Cécile Le Page, et al.
Cancer Chemotherapy and Pharmacology|July 20, 2004
Chemosensitivity and radiosensitivity profiles of four new human epithelial ovarian cancer cell lines exhibiting genetic alterations in BRCA2, TGFbeta-RII, KRAS2, TP53 and/or CDNK2AV Samouëlian, C M Maugard, M Jolicoeur, et al.
International Journal of Oncology|January 29, 2013
FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcomeMichael C J Quinn, Paulina M Wojnarowicz, Amy Pickett, et al.
British Journal of Cancer|January 20, 2006
Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancerC Le Page, V Ouellet, J Madore, et al.
International Journal of Cancer|June 15, 2019
Lifetime recreational moderate-to-vigorous physical activity and ovarian cancer risk: A case-control studyAnne Grundy, Vikki Ho, Michal Abrahamowicz, et al.
Translational Oncology|August 7, 2010
Effect of ovarian cancer ascites on cell migration and gene expression in an epithelial ovarian cancer in vitro modelLiliane Meunier, Marie-Line Puiffe, Cécile Le Page, et al.
The Journal of Pathology|December 8, 2009
Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinomaJason Madore, Fengge Ren, Ali Filali-Mouhim, et al.
International Journal of Cancer|March 31, 2006
Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancerVéronique Ouellet, Marie-Claude Guyot, Cécile Le Page, et al.
British Journal of Cancer|November 15, 2007
A Phase II study of trabectedin single agent in patients with recurrent ovarian cancer previously treated with platinum-based regimensC N Krasner, D S McMeekin, S Chan, et al.
Pageof 11